JP3121611B2 - 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター - Google Patents

神経成長因子を真核生物細胞において発現させるための遺伝子ベクター

Info

Publication number
JP3121611B2
JP3121611B2 JP02312577A JP31257790A JP3121611B2 JP 3121611 B2 JP3121611 B2 JP 3121611B2 JP 02312577 A JP02312577 A JP 02312577A JP 31257790 A JP31257790 A JP 31257790A JP 3121611 B2 JP3121611 B2 JP 3121611B2
Authority
JP
Japan
Prior art keywords
fragment
ngf
human
bamhi
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP02312577A
Other languages
English (en)
Japanese (ja)
Other versions
JPH03224490A (ja
Inventor
フランセスコ・デラ・ヴァッレ
ランフランコ・カレガロ
アレサンドロ・ネグロ
Original Assignee
フィディーア・ソシエタ・ペル・アチオニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フィディーア・ソシエタ・ペル・アチオニ filed Critical フィディーア・ソシエタ・ペル・アチオニ
Publication of JPH03224490A publication Critical patent/JPH03224490A/ja
Application granted granted Critical
Publication of JP3121611B2 publication Critical patent/JP3121611B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP02312577A 1989-11-16 1990-11-16 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター Expired - Fee Related JP3121611B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT04856489A IT1238348B (it) 1989-11-16 1989-11-16 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
IT48564A89 1989-11-16

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2000133485A Division JP2001000194A (ja) 1989-11-16 2000-05-02 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター

Publications (2)

Publication Number Publication Date
JPH03224490A JPH03224490A (ja) 1991-10-03
JP3121611B2 true JP3121611B2 (ja) 2001-01-09

Family

ID=11267348

Family Applications (2)

Application Number Title Priority Date Filing Date
JP02312577A Expired - Fee Related JP3121611B2 (ja) 1989-11-16 1990-11-16 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター
JP2000133485A Pending JP2001000194A (ja) 1989-11-16 2000-05-02 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2000133485A Pending JP2001000194A (ja) 1989-11-16 2000-05-02 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター

Country Status (22)

Country Link
US (1) US5457034A (https=)
EP (1) EP0432510B1 (https=)
JP (2) JP3121611B2 (https=)
KR (1) KR910009929A (https=)
CN (1) CN1051934A (https=)
AR (1) AR246983A1 (https=)
AT (1) ATE214735T1 (https=)
CA (1) CA2030108C (https=)
DE (1) DE69033937T2 (https=)
ES (1) ES2173856T3 (https=)
FI (1) FI905691L (https=)
HU (1) HUT61047A (https=)
IE (1) IE904120A1 (https=)
IL (1) IL96347A (https=)
IT (1) IT1238348B (https=)
NZ (1) NZ236058A (https=)
PE (1) PE28191A1 (https=)
PL (1) PL287811A1 (https=)
PT (1) PT95911B (https=)
TW (1) TW205069B (https=)
YU (1) YU217890A (https=)
ZA (1) ZA909122B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169762A (en) * 1983-03-03 1992-12-08 Genentech, Inc. Human nerve growth factor by recombinant technology
US6090781A (en) * 1996-11-06 2000-07-18 Genentech, Inc. Stabilizing formulation for NGF
US6964947B1 (en) 1995-11-07 2005-11-15 Genentech, Inc. Stabilizing formulation for NGF
AU1447600A (en) * 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
DE60040678D1 (en) 1999-09-29 2008-12-11 Gen Hospital Corp Parathyroid hormon (pth) polypeptidderivate
EP1305040B1 (en) * 2000-07-28 2009-09-09 Christopher J. Murphy Transplant media
CA2454275C (en) * 2001-07-23 2012-10-23 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
US7795220B2 (en) 2003-03-19 2010-09-14 The General Hospital Corporation Conformationally constrained parathyroid hormones with alpha-helix stabilizers
WO2005009358A2 (en) 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
CN101260398B (zh) * 2007-03-07 2013-06-05 舒泰神(北京)生物制药股份有限公司 神经生长因子基因定位改造动物及其制备方法和应用
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
CN101927012B (zh) * 2009-06-26 2013-08-14 丽珠医药集团股份有限公司 神经生长因子的病毒灭活方法
WO2011143406A2 (en) 2010-05-13 2011-11-17 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
CN102816766A (zh) * 2012-05-04 2012-12-12 沈阳医学院 蛇毒神经生长因子活性多肽的筛选方法
JP2024527197A (ja) * 2021-07-30 2024-07-23 チェンドゥ ユノヴェル バイオファーマ カンパニー リミテッド. 組換えcho細胞、その構築方法、並びにそれを用いた検出システム及び方法
CN115894705A (zh) * 2021-09-30 2023-04-04 三生国健药业(上海)股份有限公司 一种β-NGF融合蛋白、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161152C (da) * 1983-03-03 1991-11-11 Genentech Inc Polypeptid med egenskaber som human beta-nervevaekstfaktor og fremgangsmaade til fremstilling deraf, dna-isolat omfattende en sekvens som koder for polypeptidet, replicerbar udtrykkelsesvektor for dna-sekvensen, rekombinant vaertscelle transformeret med vektoren, farmaceutisk praeparat indeholdende polypeptidet og fremg. der omfatter anvendelsen af polypeptidet til fremst. af et farmaceutisk praeparat
US4796580A (en) * 1987-09-11 1989-01-10 Allied-Signal Inc. Idle control valve for use with a throttle assembly of an internal combustion engine
JPH01211490A (ja) * 1988-02-19 1989-08-24 Tosoh Corp ヒト神経成長因子遺伝子セグメント
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Bio/Technology,Vol.5,No.7(1987)p.720−725
Gene,Vol.51,No.2−3(1987)p.197−204
Neurobiol.Aging,Vol.10,No.1(1989.Jan.−Feb.)p.89−94

Also Published As

Publication number Publication date
YU217890A (sh) 1993-05-28
PT95911A (pt) 1991-09-13
JPH03224490A (ja) 1991-10-03
ES2173856T3 (es) 2002-11-01
IL96347A0 (en) 1991-08-16
FI905691A7 (fi) 1991-05-17
IL96347A (en) 1997-11-20
KR910009929A (ko) 1991-06-28
IT8948564A1 (it) 1991-05-16
CA2030108C (en) 1998-04-28
EP0432510B1 (en) 2002-03-20
TW205069B (https=) 1993-05-01
DE69033937D1 (de) 2002-04-25
ZA909122B (en) 1991-09-25
HU907174D0 (en) 1991-05-28
AU645998B2 (en) 1994-02-03
US5457034A (en) 1995-10-10
IT1238348B (it) 1993-07-13
EP0432510A1 (en) 1991-06-19
FI905691A0 (fi) 1990-11-16
IT8948564A0 (it) 1989-11-16
PL287811A1 (en) 1991-12-02
NZ236058A (en) 1993-04-28
ATE214735T1 (de) 2002-04-15
AR246983A1 (es) 1994-10-31
JP2001000194A (ja) 2001-01-09
HUT61047A (en) 1992-11-30
CA2030108A1 (en) 1991-05-17
FI905691L (fi) 1991-05-17
AU6655890A (en) 1991-05-23
PE28191A1 (es) 1991-10-28
DE69033937T2 (de) 2002-11-14
PT95911B (pt) 1998-01-30
IE904120A1 (en) 1991-05-22
CN1051934A (zh) 1991-06-05

Similar Documents

Publication Publication Date Title
JP3121611B2 (ja) 神経成長因子を真核生物細胞において発現させるための遺伝子ベクター
JP3276933B2 (ja) エリスロポエチン活性を有する糖蛋白質の製造方法
CA2406807C (en) Methods and compositions for the prevention and treatment of anemia
US7087411B2 (en) Fusion protein capable of binding VEGF
KR100467751B1 (ko) 생체내 에리스로포이에틴 활성이 증진된 융합단백질
JPS63503275A (ja) ファクター8:cの製造方法
AU634733B2 (en) Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
US20040115775A1 (en) Homogeneity and secretion of recombinant proteins in mammalian systems
JP4493854B2 (ja) リガンドの生物学的活性を増強する方法
US20050250185A1 (en) OGH fusion polypeptides and therapeutic uses thereof
WO2005058953A2 (en) Ogh fusion polypeptides and therapeutic uses thereof
EP0446931A1 (en) Human ciliary neuronotrophic factor, DNA sequence encoding the factor, and production of the factor by recombinant technology
WO1993010233A1 (en) Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor
EP0444638A2 (en) Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus
CN117683143A (zh) 一种编码血管内皮生长因子A融合蛋白的mRNA分子及其应用
CA2192738A1 (en) Truncated form of inhibitory kappa b protein (lkb), recombinant production and uses thereof
KR20010022127A (ko) 상동 재조합에 의해 사람 세포에서 사람 변이 단백질을생성시키는 방법
JPH07165796A (ja) トロンボモジュリン類発現用シグナルペプチド
JPH03136000A (ja) 糖鎖を有するb細胞分化因子

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees